- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
| home:index [06.11.2018] – [Notes and comments] sallieq | home:index [11.02.2018] – sallieq | ||
|---|---|---|---|
| Line 24: | Line 24: | ||
| {{indexmenu> | {{indexmenu> | ||
| - | ==== Autoimmunity Research Foundation ==== | ||
| - | {{indexmenu> | ||
| - | ==== Starting the Protocol | + | ==== Diagnostic tests ==== |
| - | {{indexmenu> | + | {{indexmenu> |
| + | ==== Symptoms ==== | ||
| + | {{indexmenu> | ||
| ==== Diseases ==== | ==== Diseases ==== | ||
| Line 36: | Line 36: | ||
| - | ==== Symptoms | + | ==== Health, Food & Drink ==== |
| - | {{indexmenu> | + | {{indexmenu> |
| - | ==== Diagnostic tests ==== | + | |
| - | {{indexmenu> | + | ==== Starting the Protocol |
| + | {{indexmenu> | ||
| ==== Marshall Protocol ==== | ==== Marshall Protocol ==== | ||
| {{indexmenu> | {{indexmenu> | ||
| - | |||
| - | |||
| - | ==== Non-MP treatments ==== | ||
| - | {{indexmenu> | ||
| - | |||
| - | |||
| - | ==== Food & drink ==== | ||
| - | {{indexmenu> | ||
| Line 75: | Line 69: | ||
| ==== Science behind Pathogenesis ==== | ==== Science behind Pathogenesis ==== | ||
| {{indexmenu> | {{indexmenu> | ||
| + | |||
| + | |||
| ==== Alternate models ==== | ==== Alternate models ==== | ||
| {{indexmenu> | {{indexmenu> | ||
| + | |||
| + | |||
| + | ==== Non-MP treatments ==== | ||
| + | {{indexmenu> | ||
| + | |||
| + | |||
| + | |||
| + | ==== Autoimmunity Research Foundation ==== | ||
| + | {{indexmenu> | ||
| Line 99: | Line 104: | ||
| ~~TAGCLOUD: | ~~TAGCLOUD: | ||
| --></ | --></ | ||
| + | |||
| + | |||
| ===== Incomplete articles ===== | ===== Incomplete articles ===== | ||
| Line 104: | Line 111: | ||
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| - | Sample PubMed cite(({{pubmed> | + | |
| handy link from Ron https:// | handy link from Ron https:// | ||
| Line 110: | Line 117: | ||
| with bjY08k1ZYvo 'Is there a role for a Tin-Foil hat in PPPM?' presented to the EPMA World Congress : University of Bonn September 2015 | with bjY08k1ZYvo 'Is there a role for a Tin-Foil hat in PPPM?' presented to the EPMA World Congress : University of Bonn September 2015 | ||
| - | sample page layout | ||
| - | Symptoms | ||
| - | Management | ||
| - | Recent Research | ||
| - | Evidence of infectious cause | ||
| - | Patient interviews | ||
| - | Patients experiences | ||
| - | References | ||
| - | --- //Sallie Q 07.09.2017// | + | |
| + | |||
| + | {{section>: | ||
| + | **To copy section from anor page** | ||
| + | |||
| + | |||
| + | --- //Sallie Q 07.09.2017// | ||
| https:// | https:// | ||
| Line 131: | Line 137: | ||
| https:// | https:// | ||
| + | https:// | ||
| watch for media mentions in any thread to add here https:// | watch for media mentions in any thread to add here https:// | ||
| Line 139: | Line 146: | ||
| D debate https:// | D debate https:// | ||
| - | DONE --- //Sallie Q 08.21.2017// | ||
| - | LATER in year with ' Immune Disease and the Microbiome: Healthcare in response to New Knowledge' | ||
| - | Moscow, Russia - September, 2016 | ||
home/index.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.